Mumbai, a pharmaceutical powerhouse , hosts several major players in the Carboplatin Active Pharmaceutical Ingredient (API) synthesis landscape. A number of companies , including Cipla, are known to manufacture Carboplatin API (CAS No: 41575-94-4) complying with stringent regulatory standards. Th